CHEYRL PHINNEY: Open Payments
NPI 1770804957 · BREMERTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79 in 5 payments from 3 companies in 2025. Trend: 2023 $137 · 2024 $172 · 2025 $79
Food & beverage: $79
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across WA — which companies pay providers there.
